VLP Therapeutics, Inc.

Gaithersburg, MD

UEI
M298V1FG5C14
CAGE
735F9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
704 Quince Orchard Rd #110, Gaithersburg, MD 20878, USA
Website
vlptherapeutics.com
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Research & Consulting Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of a novel virus-like particle vaccine-based cancer immunotherapy targeting PD-L1. R43CA217445 National Cancer Institute (NIH) $292,964
The completion of CMC development and production of pilot-scale cgmp losts of VLPM01, a malaria vaccine candidate W81XWH1610330 Department of Defense $2,490,865

Quick answers

Is VLP Therapeutics, Inc. registered in SAM.gov?

Yes. VLP Therapeutics, Inc.'s SAM.gov registration is active through January 29, 2027.

What is VLP Therapeutics, Inc.'s most recent federal award?

VLP Therapeutics, Inc.'s most recent federal grant award is Development of a novel virus-like particle vaccine-based cancer immunotherapy targeting PD-L1 (R43CA217445), from National Cancer Institute (NIH), on September 20, 2017.

On GovTribe

See VLP Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login